Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Culver

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Nutrition (Burbank, Los Angeles County, Calif.)|December 12, 2007
A randomized clinical trial comparing low-glycemic index versus ADA dietary education among individuals with type 2 diabetesYunsheng Ma, Barbara C Olendzki, Philip A Merriam, et al.
The American Journal of Gastroenterology|April 20, 2016
Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK CohortEmma L Culver, Ross Sadler, Dawn Simpson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2022
A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitisDaniel E Radford-Smith, Emmanuel A Selvaraj, Rory Peters, et al.
Endoscopic Ultrasound|January 2, 2023
Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis - A review of cholangiographic and ultrasound imagingKathleen Möller, Barbara Braden, Emma L Culver, et al.
Rheumatology and Therapy|March 17, 2026
Efficacy and Safety of Obexelimab to Treat IgG4-Related Disease: Protocol for a Global, Randomized, Placebo-Controlled TrialEmma L Culver, Matthew C Baker, Emanuel Della-Torre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2020
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitisEmma L Culver, Helen K Bungay, Margaret Betts, et al.
Proceedings (Baylor University. Medical Center)|August 7, 2019
A medical student perspective on solutions for burnoutGraham R Aufricht, Jonathan H Brewer, Ashlee L Culver, et al.
Rheumatology and Therapy|October 4, 2023
Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled TrialCory Perugino, Emma L Culver, Arezou Khosroshahi, et al.
BMC Medical Imaging|March 4, 2026
Periductal iron-corrected T1 is a predictor of adverse outcomes in large-duct primary sclerosing cholangitisEmmanuel A Selvaraj, Ahmed Ba-Ssalamah, Sarah Poetter-Lang, et al.
The American Journal of Gastroenterology|August 27, 2014
Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohortMatthew T Huggett, E L Culver, M Kumar, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Nutrition (Burbank, Los Angeles County, Calif.)|December 12, 2007
A randomized clinical trial comparing low-glycemic index versus ADA dietary education among individuals with type 2 diabetesYunsheng Ma, Barbara C Olendzki, Philip A Merriam, et al.
The American Journal of Gastroenterology|April 20, 2016
Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK CohortEmma L Culver, Ross Sadler, Dawn Simpson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2022
A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitisDaniel E Radford-Smith, Emmanuel A Selvaraj, Rory Peters, et al.
Endoscopic Ultrasound|January 2, 2023
Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis - A review of cholangiographic and ultrasound imagingKathleen Möller, Barbara Braden, Emma L Culver, et al.
Rheumatology and Therapy|March 17, 2026
Efficacy and Safety of Obexelimab to Treat IgG4-Related Disease: Protocol for a Global, Randomized, Placebo-Controlled TrialEmma L Culver, Matthew C Baker, Emanuel Della-Torre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2020
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitisEmma L Culver, Helen K Bungay, Margaret Betts, et al.
Proceedings (Baylor University. Medical Center)|August 7, 2019
A medical student perspective on solutions for burnoutGraham R Aufricht, Jonathan H Brewer, Ashlee L Culver, et al.
Rheumatology and Therapy|October 4, 2023
Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled TrialCory Perugino, Emma L Culver, Arezou Khosroshahi, et al.
BMC Medical Imaging|March 4, 2026
Periductal iron-corrected T1 is a predictor of adverse outcomes in large-duct primary sclerosing cholangitisEmmanuel A Selvaraj, Ahmed Ba-Ssalamah, Sarah Poetter-Lang, et al.
The American Journal of Gastroenterology|August 27, 2014
Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohortMatthew T Huggett, E L Culver, M Kumar, et al.
Pageof 12